Exciting times ahead. Happy to hold this stock and enjoy the ride up. NAN is building a solid foundation for years ahead. Still growing in size and will only get bigger.
Key things I'm looking forward to:
- Targeting introduction of the next significant new product for end of FY20, subject toregulatory approval.
- FY20 profit will be heavily weighted to H2 FY20, taking into consideration: the plannedincreased investment in new products and geographical expansion of the base trophonbusiness; phasing of trophon sales; and the realisation of consumables margin benefitassociated with the new GE Healthcare distribution agreement, the full benefit of which comesinto effect in H2 FY20.- Upgrades/replacements of trophon EPR units over five years old to increase. Meaning increased revenue.- In July 2019, the renegotiated distribution agreement with GE Healthcare in the USA cameinto effect. This new agreement expands distribution opportunities globally with GEHealthcare and also results in a material increase in both sales and margin from consumablesin North America, the full impact of which will be realised from H2 FY20.
Ann: 2019 Annual Report, page-2
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.91 |
Change
-0.020(0.68%) |
Mkt cap ! $881.6M | |||
| Open | High | Low | Value | Volume |
| $2.90 | $2.96 | $2.87 | $1.567M | 537.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 10098 | $2.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.93 | 1171 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.91 |
Change
-0.020 ( 0.70 %) |
||||
| Open | High | Low | Volume | ||
| $2.93 | $2.95 | $2.87 | 135970 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| NAN (ASX) Chart |